Načítá se...
Differential effects of somatostatin and angiopeptin on cell proliferation
1. Somatostatin (SRIF) exerts antiproliferative effects, and angiopeptin (an sst(2)/sst(5) receptor-selective analogue) has recently been evaluated in clinical trials for the prophylaxis of restenosis following coronary angioplasty. Using an in vitro model of cell growth we have examined the effects...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
1998
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1565396/ https://ncbi.nlm.nih.gov/pubmed/9641549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0701843 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|